Drug
Sdn 037
Sdn 037: highest development phase Phase 3, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SDN-037 NCT03426267 | Phase 3 | Inflammation and Pain Associated With Ocular Surgery |
Latest
No recent events.
Follow Sdn 037 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.